{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:48:39Z","timestamp":1792036119672,"version":"4.4.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.prp.2026.156421","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:21:28Z","timestamp":1771950088000},"page":"156421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Antibody-based nanoparticles in Alzheimer\u2019s disease: Innovations in diagnosis and therapy"],"prefix":"10.1016","volume":"281","author":[{"given":"Faheem","family":"Patwekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsina","family":"Patwekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Seong","family":"wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3682-3573","authenticated-orcid":false,"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arifullah","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156421_bib1","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.prp.2026.156421_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.arr.2015.07.002","article-title":"Slowing the progression of Alzheimer\u2019s disease; what works?","volume":"23","author":"Nelson","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.prp.2026.156421_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pneurobio.2011.11.008","article-title":"The future of Alzheimer's disease: the next 10 years","volume":"95","author":"Hampel","year":"2011","journal-title":"Prog. Neurobiol."},{"issue":"17","key":"10.1016\/j.prp.2026.156421_bib4","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.3390\/ijms22179207","article-title":"Tau protein interaction partners and their roles in Alzheimer\u2019s disease and other tauopathies","volume":"22","author":"Sinsky","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5968131","article-title":"Nanomaterials: a potential hope for life sciences from bench to bedside","volume":"2022","author":"Shinde","year":"2022","journal-title":"J. Nanomater."},{"issue":"102776","key":"10.1016\/j.prp.2026.156421_bib6","first-page":"10","article-title":"Artificial intelligence for drug discovery and development in Alzheimer\u2019s disease","volume":"85","author":"Qiu","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"10","key":"10.1016\/j.prp.2026.156421_bib7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.31083\/j.fbl2810258","article-title":"Alzheimer's disease; mechanism, mutations, and applications of nano-medicine","volume":"28","author":"Maisam","year":"2023","journal-title":"Front. Biosci. Landmark"},{"issue":"10","key":"10.1016\/j.prp.2026.156421_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100008","article-title":"Nanotechnology-based strategies for early diagnosis of central nervous system disorders","volume":"1","author":"Hanif","year":"2021","journal-title":"Adv. NanoBiomed Res."},{"key":"10.1016\/j.prp.2026.156421_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101654","article-title":"Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis","volume":"47","author":"Li","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.prp.2026.156421_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jconrel.2023.07.004","article-title":"Emerging nanotechnology for Alzheimer's disease: From detection to treatment","volume":"360","author":"Song","year":"2023","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.prp.2026.156421_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tibtech.2019.12.021","article-title":"Enabling technologies for personalized and precision medicine","volume":"38","author":"Ho","year":"2020","journal-title":"Trends Biotechnol."},{"issue":"5","key":"10.1016\/j.prp.2026.156421_bib12","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.19.5.051205","article-title":"Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer\u2019s disease pathogenic factor","volume":"19","author":"Kim","year":"2014","journal-title":"J. Biomed. Opt."},{"issue":"7","key":"10.1016\/j.prp.2026.156421_bib13","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/polym13071051","article-title":"Potential role of nanoparticles in treating the accumulation of amyloid-beta peptide in Alzheimer\u2019s patients","volume":"13","author":"Abbas","year":"2021","journal-title":"Polymers"},{"issue":"5","key":"10.1016\/j.prp.2026.156421_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/cells10051175","article-title":"Physiological and pathological inflammation induced by antibodies and pentraxins","volume":"10","author":"Geyer","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13024-017-0172-1","article-title":"Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency","volume":"12","author":"Agadjanyan","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.prp.2026.156421_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.60084\/mp.v1i2.60","article-title":"Integrating genetic algorithm and LightGBM for QSAR modeling of acetylcholinesterase inhibitors in Alzheimer's disease drug discovery","volume":"1","author":"Noviandy","year":"2023","journal-title":"Malacca Pharm."},{"issue":"17","key":"10.1016\/j.prp.2026.156421_bib17","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.cell.2021.07.006","article-title":"Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope","volume":"184","author":"Kim","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.prp.2026.156421_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bcp.2013.12.020","article-title":"Immunotherapy for Alzheimer's disease","volume":"88","author":"Wisniewski","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.prp.2026.156421_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41423-020-00530-6","article-title":"Human immunology and immunotherapy: main achievements and challenges","volume":"18","author":"Varad\u00e9","year":"2021","journal-title":"Cell. & Mol. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/adhm.201200268","article-title":"Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective","volume":"2","author":"Leleux","year":"2013","journal-title":"Adv. Healthc. Mater."},{"issue":"26","key":"10.1016\/j.prp.2026.156421_bib21","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1073\/pnas.1308345110","article-title":"Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium","volume":"110","author":"Kolhar","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2026.156421_bib22","unstructured":"Potemkin, N. (2017). Regulation of Zn2+ and aggregation affects A\u03b21-42-induced changes in cell culture viability (Doctoral dissertation, University of Otago)."},{"key":"10.1016\/j.prp.2026.156421_bib23","unstructured":"Fung, H.C. (2007). Genetic characterisation of neurodegenerative disorders. University of London, University College London (United Kingdom)."},{"key":"10.1016\/j.prp.2026.156421_bib24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ijbiomac.2021.06.191","article-title":"Advances in antibody nanoconjugates for diagnosis and therapy: a review of recent studies and trends","volume":"185","author":"Kadkhoda","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2026.156421_bib25","first-page":"465","article-title":"Antigen\u2013antibody complexes. Vertebrate and invertebrate respiratory proteins, lipoproteins and","author":"Kapingidza","year":"2020","journal-title":"Other body Fluid Proteins"},{"key":"10.1016\/j.prp.2026.156421_bib26","article-title":"Receptor-based approaches and therapeutic targets in Alzheimer\u2019s disease along with role of AI in drug designing: Unraveling pathologies and advancing treatment strategies","volume":"6","author":"Patwekar","year":"2023","journal-title":"Chem. Eng."},{"issue":"5","key":"10.1016\/j.prp.2026.156421_bib27","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1021\/acs.chemrev.5b00148","article-title":"Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy","volume":"116","author":"Chen","year":"2016","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/1061186X.2021.1927055","article-title":"New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease","volume":"30","author":"Ouyang","year":"2022","journal-title":"J. Drug Target."},{"key":"10.1016\/j.prp.2026.156421_bib29","series-title":"On the response of brain vasculature to focused ultrasound and microbubbles","author":"McMahon","year":"2019"},{"issue":"1-2","key":"10.1016\/j.prp.2026.156421_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/hum.2019.174","article-title":"Anti-phospho-tau gene therapy for chronic traumatic encephalopathy","volume":"31","author":"Sacramento","year":"2020","journal-title":"Hum. gene Ther."},{"key":"10.1016\/j.prp.2026.156421_bib31","article-title":"6th European Conference on Schizophrenia Research: Advancing Research-Promoting Recovery","volume":"267","author":"Gaebel","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"19","key":"10.1016\/j.prp.2026.156421_bib32","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1039\/C7CS00219J","article-title":"Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems","volume":"46","author":"Wen","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.prp.2026.156421_bib33","unstructured":"Q. Yang, 2014, Development theranostics nanomaterials (Doctoral dissertation University Kansas)."},{"issue":"6","key":"10.1016\/j.prp.2026.156421_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/17425247.2018.1471058","article-title":"Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region","volume":"15","author":"Agrawal","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"issue":"5","key":"10.1016\/j.prp.2026.156421_bib35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood\u2013brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.prp.2026.156421_bib36","unstructured":"Laksitorini, M. (2021). Examination of Wnt\/\u03b2-catenin signaling in the blood-brain barrier: exploration in a human BBB culture model under normal and pathophysiological conditions."},{"issue":"11","key":"10.1016\/j.prp.2026.156421_bib37","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood\u2013brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.prp.2026.156421_bib38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","article-title":"Recent advances in drug delivery and targeting to the brain","volume":"350","author":"Sethi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.prp.2026.156421_bib39","unstructured":"Kaur, G. (2020). Nanoparticles based drug delivery platform to improve oral uptake for the treatment of Alzheimer\u2019s disease."},{"key":"10.1016\/j.prp.2026.156421_bib40","unstructured":"Pasa, M. (2023). Nanoparticles as a Vehicle for a Novel Neuroprotective Drug to Fight Alzheimer\u00b4 s Disease (Master's thesis, Universidade do Porto (Portugal))."},{"key":"10.1016\/j.prp.2026.156421_bib41","series-title":"Polymeric nanomaterials in nanotherapeutics","author":"Vasile","year":"2018"},{"issue":"9","key":"10.1016\/j.prp.2026.156421_bib42","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3390\/pharmaceutics14091976","article-title":"Curcumin-loaded mesoporous silica nanoparticles dispersed in thermo-responsive hydrogel as potential Alzheimer disease therapy","volume":"14","author":"Ribeiro","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.prp.2026.156421_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jalz.2009.01.028","article-title":"Early identification and treatment of Alzheimer's disease: social and fiscal outcomes","volume":"5","author":"Weimer","year":"2009","journal-title":"Alzheimer's. & Dement."},{"issue":"13","key":"10.1016\/j.prp.2026.156421_bib44","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2174\/1381612822666161226151011","article-title":"Targeted nanoparticles for the treatment of Alzheimer's disease","volume":"23","author":"Martin-Rapun","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.prp.2026.156421_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.601626","article-title":"Biodegradable polymeric nanoparticles for drug delivery to solid tumors","volume":"12","author":"Gagliardi","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/21691401.2014.955107","article-title":"Application of gold nanoparticles in biomedical and drug delivery","volume":"44","author":"Daraee","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"21","key":"10.1016\/j.prp.2026.156421_bib47","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/adma.200802366","article-title":"Inorganic nanoparticles for MRI contrast agents","volume":"21","author":"Na","year":"2009","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.prp.2026.156421_bib48","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2174\/0115680266295495240415114919","article-title":"Navigating the Alzheimer's Treatment Landscape: Unraveling Amyloid-beta Complexities and Pioneering Precision Medicine Approaches","volume":"24","author":"Patwekar","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.prp.2026.156421_bib49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/brainsci13020213","article-title":"Current and future nano-carrier-based approaches in the treatment of Alzheimer\u2019s disease","volume":"13","author":"Kumar","year":"2023","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156421_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.prp.2026.156421_bib51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","article-title":"Microvesicle-and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells","volume":"220","author":"Saari","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.prp.2026.156421_bib52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jconrel.2022.11.043","article-title":"Pulmonary drug delivery technology enables anakinra repurposing in cystic fibrosis","volume":"353","author":"Puccetti","year":"2023","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/02652048.2023.2167011","article-title":"Polymer drug conjugates containing memantine, tacrine and cinnamic acid: Promising nanotherapeutics for the treatment of Alzheimer\u2019s disease","volume":"40","author":"Naki","year":"2023","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.prp.2026.156421_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102935","article-title":"\u03b1-bisabolol \u03b2-D-fucopyranoside as a potential modulator of \u03b2-amyloid peptide induced neurotoxicity: An in vitro & in silico study","volume":"88","author":"Jeyakumar","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.prp.2026.156421_bib55","series-title":"Nanomaterials for medical diagnosis and therapy","author":"Kumar","year":"2007"},{"key":"10.1016\/j.prp.2026.156421_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120724","article-title":"A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation","volume":"604","author":"Akel","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.prp.2026.156421_bib57","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s10072-021-05234-x","article-title":"Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment","volume":"42","author":"Asefy","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.prp.2026.156421_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104973","article-title":"Nanomedicine-based immunotherapy for Alzheimer's disease","volume":"144","author":"Hoque","year":"2023","journal-title":"Neurosci. & Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.prp.2026.156421_bib59","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1021\/bm3011177","article-title":"Engineered polymer nanoparticles containing hydrophobic dipeptide for inhibition of amyloid-\u03b2 fibrillation","volume":"13","author":"Skaat","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.prp.2026.156421_bib60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbi.2019.02.002","article-title":"The influence of immune activation at early vs late gestation on fetal NRG1-ErbB4 expression and behavior in juvenile and adult mice offspring","volume":"79","author":"Dabbah-Assadi","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.prp.2026.156421_bib61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.fsi.2004.03.004","article-title":"Effect of ammonia on the immune response of Taiwan abalone Haliotis diversicolor supertexta and its susceptibility to Vibrio parahaemolyticus","volume":"17","author":"Cheng","year":"2004","journal-title":"Fish. & Shellfish Immunol."},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/08982104.2018.1430829","article-title":"Effective suppression of tumour cells by oligoclonal HER2-targeted delivery of liposomal doxorubicin","volume":"29","author":"Farasat","year":"2019","journal-title":"J. liposome Res."},{"key":"10.1016\/j.prp.2026.156421_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.144155","article-title":"Unforeseen consequences of synergizing PEGylated rapamycin and quercetin in angiogenesis and metastasis inhibition: Turning failure into benefit","volume":"470","author":"Al Amili","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.prp.2026.156421_bib64","first-page":"119","article-title":"The use of peptide and protein vectors to cross the Blood-Brain barrier for the delivery of therapeutic concentration of biologics","author":"Tian","year":"2020","journal-title":"Nanomed. Brain Drug Deliv. Publ. Online"},{"issue":"2","key":"10.1016\/j.prp.2026.156421_bib65","article-title":"New insights into affinity proteins for HER2-targeted therapy: Beyond trastuzumab","volume":"1874","author":"Akbari","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA)Reviews Cancer"},{"issue":"3","key":"10.1016\/j.prp.2026.156421_bib66","first-page":"399","article-title":"Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease","volume":"97","author":"Teipel","year":"2013","journal-title":"Med. Clin."},{"issue":"2","key":"10.1016\/j.prp.2026.156421_bib67","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1053-8119(02)00026-5","article-title":"Early diagnosis of Alzheimer\u2019s disease: contribution of structural neuroimaging","volume":"18","author":"A\u00ebl Chetelat","year":"2003","journal-title":"Neuroimage"},{"key":"10.1016\/j.prp.2026.156421_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2020.101825","article-title":"Long range early diagnosis of Alzheimer's disease using longitudinal MR imaging data","volume":"67","author":"Zhu","year":"2021","journal-title":"Med. Image Anal."},{"issue":"3","key":"10.1016\/j.prp.2026.156421_bib69","first-page":"228","article-title":"Alzheimer\u2019s disease: early diagnosis and treatment","volume":"18","author":"Chu","year":"2012","journal-title":"Hong. Kong Med. J."},{"key":"10.1016\/j.prp.2026.156421_bib70","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.colsurfb.2016.08.052","article-title":"Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer\u2019s disease","volume":"148","author":"Sun","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.prp.2026.156421_bib71","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.prp.2026.156421_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112999","article-title":"Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases","volume":"221","author":"Teixeira","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.prp.2026.156421_bib73","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2015.06.002","article-title":"PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood\u2013brain barrier","volume":"211","author":"Fornaguera","year":"2015","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.prp.2026.156421_bib74","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.it.2015.05.007","article-title":"Harnessing nanoparticles for immune modulation","volume":"36","author":"Getts","year":"2015","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.prp.2026.156421_bib75","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1021\/acs.bioconjchem.8b00548","article-title":"Passive immunotherapies for central nervous system disorders: current delivery challenges and new approaches","volume":"29","author":"Kumar","year":"2018","journal-title":"Bioconjugate Chem."},{"issue":"12","key":"10.1016\/j.prp.2026.156421_bib76","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.3390\/ijms22126442","article-title":"Brain disposition of antibody-based therapeutics: dogma, approaches and perspectives","volume":"22","author":"Kouhi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156421_bib77","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnagi.2018.00284","article-title":"Phyto-therapeutic and nanomedicinal approaches to cure Alzheimer\u2019s disease: present status and future opportunities","volume":"10","author":"Ovais","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib78","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-023-01255-0","article-title":"Association study between drug prescriptions and Alzheimer\u2019s disease claims in a commercial insurance database","volume":"15","author":"Hu","year":"2023","journal-title":"Alzheimer's. Res. & Ther."},{"issue":"10","key":"10.1016\/j.prp.2026.156421_bib79","doi-asserted-by":"crossref","first-page":"8976","DOI":"10.3390\/ijms24108976","article-title":"CSF biomarkers in the early diagnosis of mild cognitive impairment and Alzheimer\u2019s disease","volume":"24","author":"Papaliagkas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.prp.2026.156421_bib80","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/antiox12020427","article-title":"Honey and Alzheimer\u2019s Disease\u2014Current understanding and future prospects","volume":"12","author":"Shaikh","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.prp.2026.156421_bib81","doi-asserted-by":"crossref","unstructured":"Wei, M., Li, Y., Liang, M., Xi, M., & Tian, H. Artificial Intelligence Approaches for Early Detection and Diagnosis of Alzheimer's Disease: A Review. Acad J Sci Technol., 5(3), 21-215.","DOI":"10.54097\/ajst.v5i3.8015"},{"issue":"19","key":"10.1016\/j.prp.2026.156421_bib82","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2174\/092986712800784667","article-title":"Antibody-conjugated nanoparticles for therapeutic applications","volume":"19","author":"Cardoso","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.prp.2026.156421_bib83","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/10408347.2020.1864716","article-title":"Nanoarchitectured bioconjugates and bioreceptors mediated surface plasmon resonance biosensor for in vitro diagnosis of Alzheimer\u2019s disease: development and future prospects","volume":"52","author":"Nangare","year":"2022","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"2","key":"10.1016\/j.prp.2026.156421_bib84","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/1061186X.2024.2417012","article-title":"Emerging advances in nano-biomaterial assisted amyloid beta chimeric antigen receptor macrophages (CAR-M) therapy: reducing plaque burden in Alzheimer\u2019s disease","volume":"33","author":"Kushwaha","year":"2025","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/1061186X.2023.2295803","article-title":"A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches","volume":"32","author":"Al-Taie","year":"2024","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib86","article-title":"Nanoparticle therapy is a promising approach in the management and prevention of many diseases: does it help in curing Alzheimer disease?","volume":"2020","author":"Kassem","year":"2020","journal-title":"J. Nanotechnol."},{"issue":"4","key":"10.1016\/j.prp.2026.156421_bib87","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/biomedicines12040851","article-title":"Transcytosis-Driven Treatment of Neurodegenerative Disorders by mRNA-Expressed Antibody\u2013Transferrin Conjugates","volume":"12","author":"Niazi","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.prp.2026.156421_bib88","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/acsptsci.0c00224","article-title":"Flavonoid-based nanomedicines in Alzheimer\u2019s disease therapeutics: promises made, a long way to go","volume":"4","author":"Prasanna","year":"2021","journal-title":"ACS Pharmacol. & Transl. Sci."},{"key":"10.1016\/j.prp.2026.156421_bib89","series-title":"In A New Era in Alzheimer's Research","first-page":"125","article-title":"Cerebrovascular pathology and targets for the prevention of Alzheimer's disease","author":"Sheoran","year":"2025"},{"issue":"s1","key":"10.1016\/j.prp.2026.156421_bib90","first-page":"S23","article-title":"Immunotherapy in Alzheimer\u2019s disease: current status and future directions","volume":"101","author":"Vashisth","year":"2024","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"4","key":"10.1016\/j.prp.2026.156421_bib91","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1021\/acs.molpharmaceut.4c01125","article-title":"Engineering multifunctional peptide-decorated nanofibers for targeted delivery of temozolomide across the blood\u2013brain barrier","volume":"22","author":"Bellavita","year":"2025","journal-title":"Mol. Pharm."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:25:02Z","timestamp":1774121102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":91,"alternative-id":["S0344033826000725"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156421","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-based nanoparticles in Alzheimer\u2019s disease: Innovations in diagnosis and therapy","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156421"}}